Dosage Charts Calculator Blends & Stacks Learn Blog Peptides
Open Calculator
Blog  ›  Melanotan II: What the Research Actually Shows

Melanotan II: What the Research Actually Shows

Jun 11, 2026 4 min Other
TL;DR
Melanotan II is a lab-made peptide that activates receptors linked to skin pigmentation, sexual function, and brain chemistry. Early animal studies hint at roles in memory and social behavior, but human safety data is thin and serious side effects have been reported. It remains a research compound, not an approved medicine.

What Is Melanotan II?

Melanotan II (often shortened to MT-II) is a synthetic — meaning lab-made — peptide. A peptide is just a short chain of amino acids, the same building blocks that make up proteins. MT-II was designed to mimic a natural hormone called alpha-melanocyte-stimulating hormone (α-MSH). That hormone tells your body to produce melanin, the pigment that darkens skin and hair.

MT-II is what scientists call a non-selective melanocortin receptor agonist. In plain English: it switches on a family of receptors (the melanocortin receptors, or MCRs) scattered throughout the body and brain. Because those receptors are involved in so many systems — skin, appetite, sexual arousal, mood — MT-II has wide-ranging effects.[1]

It is not approved by any major medicines regulator for human use. It is sold online and used without medical supervision, which raises serious concerns researchers have flagged repeatedly.[6]

Why Do People Use It? (And Why Researchers Study It)

Online forum studies show that many people seek MT-II primarily for a tanned appearance — often before beach holidays or bodybuilding competitions.[3] The fact that it also triggers spontaneous erections has attracted additional interest outside the lab.

But researchers have broader questions. Because melanocortin receptors are found in the brain, scientists want to know whether MT-II could one day play a role in neurological conditions, metabolic problems, or social behavior disorders. That curiosity has driven several animal studies.

What the Research Is Exploring

Memory and Diet-Induced Brain Changes

A 2023 study fed zebrafish a high-fat diet for three weeks — just about 1% of their lifespan. That short exposure caused measurable problems: worse recognition memory, higher anxiety, and less desire to explore their environment. When the fish were given MT-II, those changes reversed. Their memory, anxiety levels, and exploratory behavior returned to normal.[2] The researchers note this is the first study to show MT-II can reverse high-fat-diet-induced cognitive changes — but zebrafish are not people, so much more work is needed.

Autism-Like Behaviors in Mice

A 2019 UCLA-led study used a mouse model of autism called maternal immune activation (MIA). MIA mice show autism-like features: poor social interaction, less vocalization, and more repetitive behaviors. After seven days of continuous MT-II treatment, the mice showed significant improvements in social behavior metrics.[5] Importantly, healthy mice given MT-II showed no social changes — but they did lose significant weight, a reminder that the peptide is not without effects.[5]

Building Selective Derivatives

One limitation of MT-II is that it hits all melanocortin receptors at once, which is why its effects are so broad — and its side effects so unpredictable. Medicinal chemists published a 2022 study using a technique called CLIPS (Chemical Linkage of Peptides onto Scaffolds) to redesign MT-II's structure. They created new peptides that selectively activate just one receptor subtype (hMC1R), potentially opening a path to more targeted, safer drugs in the future.[4]

What About Safety? The Evidence Is a Warning

Here the picture gets sobering. A 2020 case report described a patient who suffered a renal infarction — a blockage cutting off blood supply to the kidney — most likely linked to MT-II use. The authors reviewed the broader literature and found that rhabdomyolysis (a dangerous breakdown of muscle tissue) and kidney failure had also been previously attributed to the compound.[1]

A BMJ report highlighted that MT-II was already spreading through the general population via unregulated internet sales as far back as 2009 — long before any robust safety data existed.[6]

A qualitative analysis of UK and Irish online forums found that users shared dosing tips, but misinformation was rife. Researchers flagged risks including contaminated products, infectious disease transmission from shared needles, polypharmacy (mixing multiple substances), and heavy sunbed use alongside MT-II injections.[3]

Where Does That Leave Us?

MT-II is genuinely interesting to science. Animal models hint it could influence memory, social behavior, and metabolic health. Chemists are using it as a scaffold to design more selective, potentially safer drug candidates. But — and this is a big but — none of this translates into a proven, safe human therapy. The gap between a promising mouse study and a medicine you can safely use is enormous.

If you are a researcher working with this compound, understanding dosing parameters used in studies is essential. Our Melanotan II dosage chart compiles the figures reported in the scientific literature in one place. You can also use our calculator to explore how published research doses scale. These tools are for research reference only — not personal use guidance.

Sources

  1. Melanotan II: a possible cause of renal infarction: review of the literature and case report. — CEN case reports, 2020. PMID 31953620.
  2. Melanotan-II reverses memory impairment induced by a short-term HF diet. — Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2023. PMID 37478579.
  3. Melanotan II User Experience: A Qualitative Study of Online Discussion Forums. — Dermatology (Basel, Switzerland), 2021. PMID 34464955.
  4. CLIPSing Melanotan-II to Discover Multiple Functionally Selective hMCR Agonists. — Journal of medicinal chemistry, 2022. PMID 35188390.
  5. Melanotan-II reverses autistic features in a maternal immune activation mouse model of autism. — PloS one, 2019. PMID 30629642.
  6. Use of melanotan I and II in the general population. — BMJ (Clinical research ed.), 2009. PMID 19224885.
See the dosage chart — Melanotan II
A melanocortin agonist researched for pigmentation and libido.
Melanotan II

FAQ

What receptors does Melanotan II act on?
MT-II is a non-selective agonist of melanocortin receptors (MC1R through MC5R). These receptors are found in skin, the brain, the reproductive system, and elsewhere. Because it activates multiple receptor subtypes at once, its effects — and side effects — are broad and wide-ranging, which is why researchers are working to create more selective derivatives.[4]
Has Melanotan II been tested in humans?
Formal clinical trials have been limited. Most human data comes from case reports and observational studies of unregulated use. A case report documented a likely MT-II-related renal infarction, and forum research reveals widespread unsupervised use with poorly understood risks.[1][3] It is not approved by any major drug regulator.
What did animal studies find about MT-II and the brain?
Two notable animal studies found promising signals. In zebrafish, MT-II reversed memory impairment and anxiety caused by a short-term high-fat diet.[2] In autism-model mice, seven days of MT-II treatment rescued social behavioral deficits.[5] These are early-stage findings in animals and cannot be directly applied to humans.
Why is unregulated Melanotan II use considered risky?
MT-II sold online is unregulated, meaning purity and dose are unverified. Reported risks include contaminated or counterfeit products, infection from shared needles, dangerous drug combinations, and excessive sunbed use alongside injections. Serious medical events including kidney damage have been reported in the medical literature.[1][3][6]
For research and educational use only. Not medical advice.